Nom du produit:(2R,3R,4S,5R)-2-(6-Amino-2-(phenylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
IUPAC Name:(2R,3R,4S,5R)-2-[6-amino-2-(phenylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
Product Overview |
2-Phenylaminoadenosine (2-PAA) is an important nucleoside analog that has been studied extensively in scientific research. It is a synthetic compound that is structurally similar to adenosine, a naturally occurring nucleoside. |
Synthesis Method |
2-Phenylaminoadenosine can be synthesized in a number of ways, including the use of chemical synthesis, enzymatic synthesis, or biotransformation. In chemical synthesis, 2-Phenylaminoadenosine is synthesized from adenosine and a phenyl group through a series of reactions. Enzymatic synthesis involves the use of enzymes to catalyze the formation of 2-Phenylaminoadenosine from adenosine, while biotransformation involves the use of microorganisms to convert adenosine into 2-Phenylaminoadenosine. |
Chemical Properties |
2-Phenylaminoadenosine is a synthetic compound that is relatively easy to synthesize and store. Additionally, 2-Phenylaminoadenosine is relatively stable and has a long shelf life. |
Synthesis and Application |
In vivo studies have utilized 2-Phenylaminoadenosine to investigate the effects of drugs on the cardiovascular system, while in vitro studies have used it to evaluate the biological activities of various drugs. |
Future Directions |
Future studies should focus on further elucidating the mechanisms of action of 2-Phenylaminoadenosine and exploring its potential therapeutic applications. Additionally, further research should focus on the development of novel synthetic methods for the synthesis of 2-Phenylaminoadenosine, as well as the development of new analogs with improved pharmacological properties. Finally, further research should focus on the development of novel delivery methods for 2-Phenylaminoadenosine, such as nanoparticles or liposomes. |